Clavobid LB Tablets Product
Preferred choice in AECOPD with high success rate
J Chemother. 2007
Clinical Efficacy Rate
81.3%
Cefaclor
90.5%
Amoxicillin-
clavulanate

Amoxycillin 500mg + Clavulanate Potassium 125mg + Lactobacillus 60 Million Spores Tablets

Tame the resistance

  • Potent broad spectrum of antibacterial activity, covers beta-lactamase-producing pathogens.
  • Used in wide range of indications for over 20 years.
  • Clavulanate has some effects on pathogenic bacteria regardless of beta-lactamase production.
  • Used empirical treatment in bacterial respiratory tract infections.
  • Available in various formulations in over 150 countries around the world.

Indicated in:

Respiratory Tract Infections Gynaecological Infections Acute Exacerbations of Chronic Bronchitis Skin and Soft Tissue Infections Community Acquired Pneumonia